Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair

• Published in: Molecules (Basel, Switzerland) Vol. 25; no. 3; p. 735
• Main Authors: Economos, Nicholas G., Oyaghire, Stanley, Quijano, Elias, Ricciardi, Adele S., Saltzman, W. Mark, Glazer, Peter M.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 08.02.2020; MDPI
• Subjects: cystic fibrosis; Deoxyribonucleic acid; DNA; gene editing; Genome editing; Investigations; nanoparticles; peptide nucleic acids; Peptides; pna; recombination; repair; Review; structure; triplex; β-thalassemia; repair; PNA; nanoparticles; recombination; cystic fibrosis; gene editing; triplex; structure; β-thalassemia; peptide nucleic acids
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules25030735

Unusual nucleic acid structures are salient triggers of endogenous repair and can occur in sequence-specific contexts. Peptide nucleic acids (PNAs) rely on these principles to achieve non-enzymatic gene editing. By forming high-affinity heterotriplex structures within the genome, PNAs have been used to correct multiple human disease-relevant mutations with low off-target effects. Advances in molecular design, chemical modification, and delivery have enabled systemic in vivo application of PNAs resulting in detectable editing in preclinical mouse models. In a model of β-thalassemia, treated animals demonstrated clinically relevant protein restoration and disease phenotype amelioration, suggesting a potential for curative therapeutic application of PNAs to monogenic disorders. This review discusses the rationale and advances of PNA technologies and their application to gene editing with an emphasis on structural biochemistry and repair.